Dermapharm Holding SE

Dermapharm Holding SE

Community score

-0.60 -55
Industry: Biotechnology & Pharmaceuticals
Listing country: Germany
Year added: 2022

Dermapharm Holding SE, incorporated in 1991, is headquartered in Grünwald, Germany. The company focuses on various business segments, with two of the most important being Branded Pharmaceuticals and Other Healthcare Products—which includes proprietary and in-licensed pharmaceuticals and other healthcare products—and Herbal Extracts, specializing in the extraction of active pharmaceutical ingredients from plants. Among Dermapharm Holding SE's key brands are Dekristol, a vitamin D supplement; Ampho-Moronal, an antifungal medication; Tromcardin, a cardiac medication; and Bite Away, a device designed for the external treatment of insect stings and bites. While the company has established a significant market presence in Germany, it also actively sells its products and services in the European market and has expanded its operations to include activities in Asia and North America. (Powered by AI)

Show Company Information
You view a limited profile page without scores and metrics availability. Subscribing users get to see more advanced data, want to see it in action? Click on a company you are interested in: .
My impact scoreBeta
List View

Most negative / positive SDG

+2.57
-3.09